Frank Condella
Chairman bei MAYNE PHARMA GROUP LIMITED
Vermögen: 311 408 $ am 31.03.2024
Profil
Frank C.
Condella is currently the Chairman at Mayne Pharma Group Ltd.
and an Independent Director at Palladio Biosciences, Inc. He previously served as the President & Chief Executive Officer at Alpharma Specialty Pharma LLC and FH Faulding & Co. Ltd.
He was also the Chief Executive Officer at Faulding Pharmaceuticals Plc.
Additionally, he held positions such as Non-Executive Vice Chairman at Vectura Group Ltd., Chairman at The Polycystic Kidney Disease Research Foundation, and Non-Executive Director at Catalent JNP, Inc. He was the President-Europe & Managing Director-UK at IVAX LLC and a Non-Executive Director at SkyePharma Plc, Fulcrum Pharma Plc, Fertin Pharma A, and Prosonix Ltd.
He also worked as the Vice President-Specialty Care Products at Roche Holding AG and Hoffmann-La Roche, Inc. Mr. Condella holds an undergraduate degree and an MBA from Northeastern University, as well as an MBA from D'Amore-Mckim School of Business.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
MAYNE PHARMA GROUP LTD.
0,08% | 01.12.2023 | 65 929 ( 0,08% ) | 311 408 $ | 31.03.2024 |
Aktive Positionen von Frank Condella
| Unternehmen | Position | Beginn |
|---|---|---|
| MAYNE PHARMA GROUP LIMITED | Chairman | 30.09.2021 |
Palladio Biosciences, Inc.
 Palladio Biosciences, Inc. BiotechnologyHealth Technology Palladio Biosciences, Inc. develops transformative medicines for orphan diseases. Its pipeline includes Lixivaptan, a selective vasopressin V2 receptor antagonist for the treatment of polycystic kidney disease, a life-threatening genetic disease. The company was founded by Lorenzo Pellegrini in 2015 and is headquartered in Newtown, PA. | Director/Board Member | - |
Ehemalige bekannte Positionen von Frank Condella
| Unternehmen | Position | Ende |
|---|---|---|
| VECTURA GROUP | Director/Board Member | 31.10.2018 |
| JUNIPER PHARMACEUTICALS INC | Chief Executive Officer | 01.08.2016 |
IVAX LLC
 IVAX LLC Pharmaceuticals: MajorHealth Technology IVAX LLC discovers, develops, manufactures, and markets generic pharmaceuticals, respiratory drugs, and cancer treatments. It offers drugs for the treatment of multiple sclerosis, brain cancer, asthma, and epilepsy. The company was founded by Phillip Frost and Jane H. Hsiao in 1987 and is headquartered in Weston, FL. | Corporate Officer/Principal | - |
Alpharma Specialty Pharma LLC
 Alpharma Specialty Pharma LLC Medical DistributorsDistribution Services Part of Pfizer Inc., Alpharma Specialty Pharma LLC is a private company that distributes multi-source injectable pharmaceutical drugs. The company is based in Paramus, NJ. | President | 01.10.2001 |
| FH Faulding & Co. Ltd. | President | 01.10.2001 |
Ausbildung von Frank Condella
| Northeastern University | Masters Business Admin |
| D'Amore-Mckim School of Business | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| ROCHE HOLDING AG | Health Technology |
| MAYNE PHARMA GROUP LIMITED | Health Technology |
| Private Unternehmen | 13 |
|---|---|
Catalent JNP, Inc.
 Catalent JNP, Inc. Pharmaceuticals: MajorHealth Technology Catalent JNP, Inc. engages in the research and development of drugs and therapeutics. It offers analytical characterization and pre-formulation testing; formulation development; and clinical manufacturing of capsules and tablets. The company was founded in December 1986 and is headquartered in Somerset, NJ. | Health Technology |
IVAX LLC
IVAX LLC Pharmaceuticals: MajorHealth Technology IVAX LLC discovers, develops, manufactures, and markets generic pharmaceuticals, respiratory drugs, and cancer treatments. It offers drugs for the treatment of multiple sclerosis, brain cancer, asthma, and epilepsy. The company was founded by Phillip Frost and Jane H. Hsiao in 1987 and is headquartered in Weston, FL. | Health Technology |
SkyePharma Plc
 SkyePharma Plc Pharmaceuticals: OtherHealth Technology SkyePharma Plc engaged in the provision of pharmaceutical business. It involved in development and supply of pharmaceutical products. The company was founded by Ian Roderick Gowrie-Smith on August 18, 1910 and was headquartered in London, the United Kingdom. | Health Technology |
Alpharma Specialty Pharma LLC
Alpharma Specialty Pharma LLC Medical DistributorsDistribution Services Part of Pfizer Inc., Alpharma Specialty Pharma LLC is a private company that distributes multi-source injectable pharmaceutical drugs. The company is based in Paramus, NJ. | Distribution Services |
Vectura Group Ltd.
 Vectura Group Ltd. Pharmaceuticals: MajorHealth Technology Vectura Group Ltd. engages in the provision of pharmaceutical development. Its activities include research, development, and commercialization of novel therapeutic products. The company operates through the following segments: Switzerland, United Kingdom, Germany, United States of America, and France. Vectura Group was founded by David Anthony Gough in 1997 and is headquartered in Chippenham, the United Kingdom. | Health Technology |
Fulcrum Pharma Plc
 Fulcrum Pharma Plc Pharmaceuticals: OtherHealth Technology Fulcrum Pharma Plc provides drug development and regulatory expertise essential to progress a development program from research to product approval. The company was founded in 1999 and is headquartered in Hemel Hempstead, the United Kingdom. | Health Technology |
| FH Faulding & Co. Ltd. | Health Technology |
Hoffmann-La Roche, Inc.
 Hoffmann-La Roche, Inc. BiotechnologyHealth Technology Hoffmann-La Roche, Inc. manufactures pharmaceutical drugs. Its products include influenza fighter Tamiflu, controversial acne medication Accutane, HIV inhibitor Fuzeon, obesity drug Xenical, and hepatitis C therapy Pegasys. The company was founded in 1896 Roche and is headquartered in Nutley, NJ. | Health Technology |
Fertin Pharma A/S
 Fertin Pharma A/S Food: Specialty/CandyConsumer Non-Durables Fertin Pharma A/S develops and manufactures medical chewing gum. It offers pharmaceutical and nutraceutical chewing gum products. The company was founded in 1915 and is headquartered in Vejle, Denmark. | Consumer Non-Durables |
Prosonix Ltd.
 Prosonix Ltd. Pharmaceuticals: MajorHealth Technology Prosonix Ltd. engages in the provision of inhaled respiratory medicines. The company was founded by Andre James Bush and David Hipkiss in 2006 and is headquartered in Oxford, the United Kingdom. | Health Technology |
| The Polycystic Kidney Disease Research Foundation | |
| Faulding Pharmaceuticals Plc | |
Palladio Biosciences, Inc.
Palladio Biosciences, Inc. BiotechnologyHealth Technology Palladio Biosciences, Inc. develops transformative medicines for orphan diseases. Its pipeline includes Lixivaptan, a selective vasopressin V2 receptor antagonist for the treatment of polycystic kidney disease, a life-threatening genetic disease. The company was founded by Lorenzo Pellegrini in 2015 and is headquartered in Newtown, PA. | Health Technology |
